4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine → 6-chloro-4-(4-methoxy-6-(4-pyridinyl)-1H-indol-1-yl)-2,3-dimethylquinoline

HRID 1618598Notes

Reaction equation

HRID 1618598 reaction equation
Br[C:2]1[CH:10]=[C:9]2[C:5]([CH:6]=[CH:7][N:8]2[C:11]2[C:20]3[C:15](=[CH:16][CH:17]=[C:18]([Cl:21])[CH:19]=3)[N:14]=[C:13]([CH3:22])[C:12]=2[CH3:23])=[C:4]([O:24][CH3:25])[CH:3]=1.CC1(C)C(C)(C)OB([C:34]2[CH:39]=[CH:38][N:37]=[CH:36][CH:35]=2)O1>>[Cl:21][C:18]1[CH:19]=[C:20]2[C:15](=[CH:16][CH:17]=1)[N:14]=[C:13]([CH3:22])[C:12]([CH3:23])=[C:11]2[N:8]1[C:9]2[C:5](=[C:4]([O:24][CH3:25])[CH:3]=[C:2]([C:34]3[CH:39]=[CH:38][N:37]=[CH:36][CH:35]=3)[CH:10]=2)[CH:6]=[CH:7]1

Participants

3

Reactant 2

HCID 27346484-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridineHCID 672850594-(6-bromo-4-methoxy-1H-indol-1-yl)-6-chloro-2,3-dimethylquinoline

Product 1

HCID 509403326-chloro-4-(4-methoxy-6-(4-pyridinyl)-1H-indol-1-yl)-2,3-dimethylquinoline

Procedure

Prepared according to procedure W using 4-(6-bromo-4-methoxy-1H-indol-1-yl)-6-chloro-2,3-dimethylquinoline (0.4 g, 0.962 mmol) and 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (0.3946 g, 1.92 mmol) to give 6-chloro-4-(4-methoxy-6-(4-pyridinyl)-1H-indol-1-yl)-2,3-dimethylquinoline as a white solid: 1H NMR (500 MHz, DMSO-d6) δ ppm 8.50 (2H, dd, J=4.6, 1.5 Hz), 8.09 (1H, d, J=8.8 Hz), 7.74 (1H, dd, J=8.9, 2.3 Hz), 7.64 (2H, dd, J=4.5, 1.6 Hz), 7.57 (1H, d, J=3.2 Hz), 7.07 (1H, s), 6.86-6.93 (3H, m), 4.07 (3H, s), 2.77 (3H, s), 2.05 (3H, s); Mass Spectrum (ESI) m/e=414.1 (M+1).

Workup

  1. customPrepared

Sources & evidence

ORD record
ord-639ad24b295d49278e40dffbc1bf8010
Source dataset
uspto-grants-2014_07
Patent number
US08765940B2

Reaction notes

Loading…